SHARE Knowledge Hub
Toxic Peripheral Neuropathy
Toxic peripheral neuropathy means peripheral nerve damage linked to a toxic exposure, but symptoms alone do not establish the cause. For suspected poisoning or harmful chemical contact, get medical advice immediately even if the person seems well; use the GB or NI urgent route below. Call 999 for sudden stroke-like signs or a severe chemical emergency. For gradual new nerve symptoms, seek GP assessment. At work, stop uncontrolled exposure, identify the substance and task, and obtain competent control and health advice. Great Britain and Northern Ireland have separate COSHH and RIDDOR rules. This page is general learning, not a diagnosis or fitness decision.
Understanding Toxic Peripheral Neuropathy
Toxic peripheral neuropathy is peripheral nerve damage attributed to a toxic agent; symptoms alone do not establish an occupational cause.
Why this matters at work
Loss of sensation can be more hazardous than pain because injury goes unnoticed. Inspect feet, footwear and skin where advised clinically; address hot work, sharp edges, vibration, chemicals and walking surfaces. A worker with reduced protective sensation should not be assigned to thermal or cutting hazards on the assumption that gloves or boots compensate for inability to detect damage.
Substitution can fail if it exchanges a known product for a poorly characterised blend. Compare hazard class, neurotoxicity, volatility, flammability, skin penetration, quantity and method. Spraying, heated use and open wiping increase vapour generation; enclosed automated use can reduce routine exposure but create maintenance peaks. Validate the chosen method with exposure monitoring where uncertainty remains.
How organisations manage this in practice
The risk assessment and equipment performance determine additional checks; a current test sticker cannot validate a broken hood or bypassed interlock. Verify controls with smoke visualisation where safe, pressure or flow indicators, exposure monitoring, containment checks and worker observation.
New numbness, pain, weakness or altered balance needs healthcare assessment and a review of plausible exposures. Managers should recognise functional risk without diagnosing the cause. Record the task and timing and prevent further harmful exposure while concerns are assessed.
The occupational history should be chronological and task specific. Record employers and sites, products and CAS numbers, mixtures, quantities, application method, temperature, ventilation, PPE, skin contact, spills, cleaning, maintenance, symptom timing, co-worker illness and whether symptoms changed away from work. Include old jobs because neuropathy may follow cumulative or historic exposure.
Provide the SDS, COSHH assessment, monitoring and competent hygiene summary with consent and through the appropriate route; do not flood the referral with irrelevant records or ask the clinician to decide whether the organisation complied with law. A later legal process may need the original versions and dates.
Identify ingredients, process conditions and all exposure routes. A mixture may require more than separate comparisons with individual exposure limits. Use current product data and competent hygiene advice to evaluate combined effects and control failures.
NHS describes sensory loss, pain, balance problems and weakness as possible neuropathy symptoms and advises GP assessment. There are many causes, including non occupational ones. Workplace exposure investigation and clinical differential diagnosis answer different questions.
What is toxic peripheral neuropathy?
Peripheral neuropathy is damage to nerves outside the brain and spinal cord. Some chemical exposures can cause it, but symptoms alone do not identify the cause.
- Verify the substance
Use the current formulation and real task, not a generic solvent label.
- Control exposure
Remove or substitute the product, then verify containment.
- Respond to concerns
Stop uncontrolled exposure and arrange a confidential clinical route.
- Check effectiveness
Compare observed work, exposure evidence and corrective action.
This is a reading route through the detailed decisions below, not a clearance to perform the task. Follow the linked sections, their official sources and the applicable local assessment.
Numbness, tingling, burning pain, weakness and loss of balance may occur. Diabetes, medicines, alcohol, injury and other conditions can also cause peripheral neuropathy. A GP or specialist assesses diagnosis and cause; an employer assesses and controls work exposure without waiting for a diagnosis.
HSE COSHH Essentials SR22 identifies n-hexane in solvent-based adhesives as a nerve-damage hazard and advises avoiding products that contain it. HSE also recognises that repeated exposure to particular solvents may cause neurological disease. Product identity, mixture, route, real duration, skin contact and existing controls matter more than a broad solvent label. Lead, asbestos and some pesticides can have separate regulatory routes; seek substance-specific advice.
Neither an SDS hazard phrase, a symptom report nor a single air sample proves toxic neuropathy. Record the concern, prevent further uncontrolled exposure and share an accurate exposure history with occupational health or the treating clinician through a confidential route.
| Observation category (not a diagnosis) | Possible symptom pattern | Workplace relevance |
|---|---|---|
| Sensory nerve effect | Tingling, numbness, burning pain or altered sensation. | May first be reported as pins and needles after solvent or metal work. |
| Motor nerve effect | Weakness, reduced grip, foot drop, cramps or clumsiness. | May affect tool use, ladders, driving, plant, manual handling or fine work. |
| Balance and coordination | Unsteady walking, slips or poor coordination. | Could create secondary safety risk in safety-critical tasks. |
| Acute solvent effect | Dizziness, drowsiness, headache, confusion or nausea. | May indicate harmful exposure or another urgent condition; stop the task, make the area safe and seek medical assessment. Symptoms alone do not prove cause or control failure. |
| Possible central nervous system effects, distinct from peripheral neuropathy | Persistent memory, mood, concentration or nerve symptoms. | Requires exposure history, OH/medical review and control investigation. |
| Delayed or progressive symptoms | Symptoms may not stop immediately when a task ends. | Do not dismiss symptoms because they are subtle or intermittent. |
Separate peripheral and central effects
Peripheral sensory effects involve sensation; motor effects involve strength and movement; autonomic effects involve involuntary functions. Balance problems need clinical assessment and can have different causes. Acute intoxication (such as dizziness or drowsiness) and possible central effects on memory, mood or concentration are separate categories; they do not diagnose peripheral neuropathy. See Organic Solvent Encephalopathy for the separate central-effects lesson. Possible poisoning and stroke signs still follow the urgent routes below.
How does exposure become nerve injury?
Trace the actual substance from purchase and use through release, inhalation or skin contact, possible uptake and health concern; separate exposure evidence from a clinical diagnosis.
For each task identify product and ingredients, quantity, application, ventilation, contaminated surfaces, waste, frequency, duration and everyone exposed. Air sampling measures inhaled concentration for the sampled work; biological monitoring measures uptake; neither is a clinical diagnosis or a substitute for health surveillance.
Do not use odour or an open door as proof of safety. Check that enclosure or local exhaust ventilation (LEV) captures releases at source, skin contact is controlled and work-as-done matches the assessment. Where evidence is missing, hold the exposure-producing step until a competent person sets and verifies interim controls.
| Pathway stage | What to examine | Control focus |
|---|---|---|
| Substance identity | SDS, composition, trade name, impurities and degradation products. | Substitute less hazardous products where possible. |
| Form and volatility | Liquid solvent, vapour, dust, aerosol or contaminated surface. | Containment, LEV, closed transfer or wet methods. |
| Inhalation route | Breathing zone exposure during use, cleaning or drying. | LEV, ventilation, enclosure and exposure monitoring. |
| Skin route | Splashes, soaked gloves, contaminated rags or tool handles. | Glove material, breakthrough time, skin hygiene and task design. |
| Ingestion route | Hand-to-mouth transfer, food or drink in work area. | Welfare, handwashing, clean/dirty separation and no eating in contaminated zones. |
| Dose over time | Frequency, duration, peaks and cumulative exposure. | WEL monitoring, biological monitoring where relevant and trigger-time control. |
| Health signal | Symptoms, health surveillance or OH findings. | Remove exposure, review controls and involve competent advice. |
What should teams check before, during and after a neurotoxic exposure task?
Confirm the substance and task, prevent release and contact, verify controls in use, stop on uncertainty or symptoms, then document a safe hand-back.
| Task, people and place | Before work | During work and hold point | After and evidence |
|---|---|---|---|
| Routine panel cleaning in a ventilated workshop; technicians and nearby staff. | Confirm current product/SDS, safer alternative, bench capture, compatible gloves, closed rag bin and competent instruction. | Check capture at the actual bench and prevent skin contact. Stop if vapour escapes, gloves fail or symptoms occur. | Close waste, clean surfaces, record checks and any concern; reopen after a verified control fix. |
| Contractor coating removal in occupied refurbishment; contractor and client staff. | Agree product, method, segregation, ventilation, access, emergency contacts and who owns the hand-back. | Hold work if product changes, barriers fail or vapour reaches others; reassess before continuing. | Inspect area, waste and residual contamination; exchange records and authorise hand-back. |
| Unlabelled cleaner or substituted product at stores; purchaser, user and others. | Quarantine until identity, label and current SDS are confirmed; assess actual use and supply conditions. | Do not trial an unknown liquid or infer glove compatibility from appearance. | Approve and label only after competent review; retain product decision and supplier information. |
| LEV fault or unusual solvent use during maintenance; maintainer and operators. | Isolate the exposure-producing task and plan a safe repair by competent people. | Do not rely on open doors or a disposable mask; hold until source capture is demonstrated. | Record repair, performance check and authorised restart under real task conditions. |
| Spill with worker symptoms; responders and nearby workers. | Know emergency plan, first aid, isolation and product details before use. | Evacuate/isolate as needed; call emergency help for serious symptoms. Do not send unprotected staff into vapour. | Preserve facts, arrange competent clean-up, review exposure/health routes and verify safe hand-back. |
How might toxic neuropathy develop in a solvent-cleaning task?
A vehicle repair bench-cleaning task illustrates why product identity, glove compatibility, capture and duration must be checked in real work.
At a repair shop, a technician repeatedly wipes panels with a solvent cleaner. The current safety data sheet (SDS) has not been checked; used rags remain open and thin gloves soften. The spray booth extraction does not necessarily capture vapour at the bench. These are exposure-control questions, not proof that any symptom was caused by work.
The supervisor pauses the bench task, offers a safe alternative and records the product, time and conditions. A competent assessor checks substitution, closed rags, suitable local capture, compatible gloves and the need for monitoring. A worker with new tingling seeks GP advice, with occupational health support and a factual exposure history. Restart only after controls are verified at the bench.
| Observation | Weak interpretation | Stronger occupational health response |
|---|---|---|
| Task listed as occasional | Exposure is low because the method statement says so. | Observe real duration, frequency and work-as-done. |
| Solvent smell in area | Smell warns people to leave if it gets bad. | Smell is not a reliable exposure indicator. |
| Disposable gloves soften | Any glove is better than no glove. | Select glove material by SDS and breakthrough time. |
| Tingling symptoms | Probably unrelated or personal. | Treat as potential health signal and review exposure. |
| No air monitoring | No evidence of a problem. | Commission competent monitoring where WEL or exposure concern exists. |
| Worker moved temporarily | Problem solved. | Review source, LEV, hygiene, waste and surveillance for the whole team. |
Which agents and product routes need a separate nerve-risk assessment?
n-Hexane and acrylamide are documented nerve hazards; other listed product groups need their own evidence, authorisation and exposure assessment before attributing symptoms.
An ingredient name is a prompt to investigate, not a diagnosis. Check the current SDS, process-generated substances, applicable GB or NI regime and credible exposure routes. Use the applicable UK substance assessment and exposure limits; a foreign limit does not replace them.
For lead, use the separate lead-at-work route; for pesticides, check the applicable product authorisation and use rules as well as health controls. Specialist review is needed where mixtures, unknowns or symptoms make the assessment uncertain.
| Agent or group | Typical workplace context | Control emphasis |
|---|---|---|
| n-Hexane | Some adhesives, cleaners and degreasing products if actually present in the formulation. | Check the SDS and substitute n-hexane where present; HSE SR22 identifies nerve damage in small-scale adhesive work. Verify the actual formulation and GB or NI controls. |
| Other solvent mixtures | Painting, coating and cleaning with variable ingredients. | Identify each product and task; HSE warns of possible long-term neurological disease for some solvents. |
| Lead and its compounds | Legacy paint, battery or specialist processes. | Use the separate lead-at-work rules and competent medical-surveillance advice; do not treat as ordinary COSHH-only work. |
| Acrylamide or specialist chemicals | Industrial or laboratory work where the ingredient is confirmed. | Seek substance-specific occupational hygiene and clinical advice; do not infer risk from a generic list. |
| Pesticide products | Authorised pest-control or agricultural use. | Check actual formulation, authorisation, label and applicable regime; do not imply all pesticides cause neuropathy. |
What should happen when symptoms are reported?
Suspected poisoning or harmful chemical contact needs immediate medical advice even without severe symptoms; sudden stroke signs or serious illness need 999. Gradual new nerve symptoms need GP assessment and a separate workplace control review.
If a substance may have been swallowed, inhaled or contacted the skin, stop exposure and make the area safe without an unprotected rescue. In England and Wales, NHS poisoning advice says call 999 or go to A&E for suspected harmful swallowing, touch or inhalation, even if symptoms are absent; use NHS 111 promptly if unsure whether the substance is harmful. In Scotland, NHS inform says call 999 for known swallowed poison; seek urgent GP/NHS 24 on 111 advice for other suspected harmful touch or inhalation, and call 999 for serious illness. In Northern Ireland, nidirect says get medical help immediately: call a GP or GP out-of-hours service if the person appears well, and go to an emergency department if prompt advice is unavailable and the substance may be hazardous. Call 999 for severe illness or breathing difficulty. Do not wait for symptoms, which can be delayed. Call 999 for sudden one-sided weakness, face droop or speech change, even if it improves. Share the container or SDS with clinicians if safely available; do not delay care to find it. Gradual unexplained tingling without an acute exposure needs GP assessment.
The supervisor records the concern without demanding a diagnosis, holds any uncontrolled exposure and any affected safety-critical task, and seeks competent advice. Consider co-workers sharing the exposure. A clinician decides the medical workup; the employer fixes exposure controls and respects confidentiality.
| Trigger | Immediate control | Follow-up |
|---|---|---|
| Sudden face, arm or speech change | Call 999 now; do not drive the person to A&E. | NHS stroke route; secure the work area separately. |
| Suspected harmful chemical contact, inhalation or swallowing, even if well | Stop exposure safely. England/Wales: 999 or A&E for suspected harmful contact; NHS 111 if unsure. Scotland: 999 for known swallowed poison or serious illness; urgent GP/NHS 24 on 111 advice for other suspected harmful contact or inhalation. NI: GP/GP out of hours immediately if well; emergency department if prompt advice unavailable. 999 for severe illness. | No unprotected rescue; share product/SDS with clinicians without delaying care. Symptoms can be delayed. |
| New tingling, pain, numbness or weakness | Arrange GP assessment and pause uncontrolled exposure. | Worker, supervisor and occupational health; factual exposure history. |
| Balance or grip change in safety-critical work | Hold the affected task pending task-specific review. | Manager and OH/clinician; no blanket fitness rule. |
| More than one worker reports symptoms | Check the shared process and controls without diagnosing the group. | Competent COSHH and occupational hygiene review. |
How should clinical concerns and workplace controls be kept separate?
Clinicians diagnose and advise on health; the workplace controls exposure, documents the task and implements proportionate task-specific advice.
A GP may investigate diabetes, medicines, injury and other causes as well as possible toxic exposure. Occupational health may advise on work impact and surveillance. Managers need the functional advice and controls, not an unrestricted clinical record.
Exposure monitoring tests airborne concentration or uptake; health surveillance looks for early work-related health effects where the regulatory criteria apply. They answer different questions. Keep individual health data restricted, with an identified lawful basis and special-category condition; share only what the manager needs for control and adjustment.
| Issue | Clinical boundary | Occupational control action |
|---|---|---|
| Symptoms and cause | GP or specialist assesses diagnosis and differential causes. | Manager records task facts and prevents uncontrolled exposure. |
| Exposure monitoring | Hygienist interprets air or biological exposure data. | Act on control findings; do not treat a sample as a diagnosis. |
| Health surveillance | Competent OH professional designs and interprets the appropriate scheme. | Employer provides it when criteria apply and closes control actions. |
| Fitness for a task | OH/clinician gives relevant functional advice where needed. | Manager reviews the actual task and temporary controls; no universal threshold. |
| Private health information | Clinical details remain in the protected health route. | Share only necessary work-impact advice with authorised people. |
Control the task and investigate the concern on separate tracks
Identify the exact substance and exposure route while arranging appropriate confidential assessment of symptoms. Neither a symptom pattern nor a single air sample establishes toxic causation.

Exact formulation
Establish the formulation, SDS, task, quantities and relevant routes. Consider removing the solvent step or validating a demonstrably lower-risk process while checking fire, skin and other new hazards.
Source and transfer controls
Use suitable closed dispensing and verified source capture, lidded waste and clean/dirty boundaries. Control skin and hand-to-mouth routes as well as inhalation.
Actual exposure history
Record relevant work duration, changes, controls and incidents. Treat measurements in their sampling and task context; a single result cannot prove the cause of an individual’s symptoms.
Sensation and movement
Peripheral nerve problems can affect feeling or muscle movement. These conceptual labels are not a nerve-conduction test, a body-map diagnosis or proof of workplace causation.
Confidential assessment
Support appropriate clinical assessment and share necessary factual exposure information through the agreed confidential route. Symptoms may have several occupational or non-work causes.
Safe assignment and review
Review safe grip, movement and safety-critical demands with the worker and relevant advice while exposure controls are corrected. Use the page’s escalation arrangements for urgent concerns.
Read the complete controls: ERICPD planning prompts
Discipline verifies and sustains all the controls; it is not a separate substitute for them.
| Prompt or level | Complete task-specific example |
|---|---|
| Eliminate | Remove the solvent-cleaning step by using pre-cleaned parts or a process that needs no chemical wipe. |
| Reduce | Trial a product or method with demonstrably lower neurological and overall health risk, checking the exact formulation, new skin/fire hazards and cleaning performance. |
| Isolate | Use a closed dispenser and suitable local exhaust ventilation at the emission point, with lidded waste and a defined clean zone; prevent solvent transfer to adjacent benches. |
| Control | Limit quantity and exposed time, train the actual method and spill response, keep food/phones out of the dirty area and investigate early symptoms without assuming a diagnosis. |
| PPE | Select gloves for the specific product and breakthrough time, eye/clothing protection, and suitable RPE only if residual inhalation risk remains after source control. |
| Discipline | Limit quantity and exposed time, train the actual method and spill response, keep food/phones out of the dirty area and investigate early symptoms without assuming a diagnosis. The COSHH owner checks observed work, exposure data and suitable surveillance advice; new symptoms or uncontrolled exposure trigger review and care. Discipline sustains every control level: verify elimination and substitution decisions, inspect and maintain physical controls, check operating arrangements and residual PPE, investigate defects and worker feedback, and verify corrective action before closure. |
Read the complete controls: ESEAP effectiveness order
Compare stronger feasible controls while preserving the actual task, checks and release requirements.
| Prompt or level | Complete task-specific example |
|---|---|
| Elimination | Remove the solvent-cleaning step by using pre-cleaned parts or a process that needs no chemical wipe. |
| Substitution | Trial a product or method with demonstrably lower neurological and overall health risk, checking the exact formulation, new skin/fire hazards and cleaning performance. |
| Engineering controls | Use a closed dispenser and suitable local exhaust ventilation at the emission point, with lidded waste and a defined clean zone; prevent solvent transfer to adjacent benches. |
| Administrative controls | Limit quantity and exposed time, train the actual method and spill response, keep food/phones out of the dirty area and investigate early symptoms without assuming a diagnosis. |
| PPE | Select gloves for the specific product and breakthrough time, eye/clothing protection, and suitable RPE only if residual inhalation risk remains after source control. |
Gloves must suit the exact formulation and contact time; RPE is conditional on the competent assessment, not prescribed by a generic icon.
What control standard is expected under COSHH?
GB COSHH 2002 and NI COSHH 2003 require prevention or adequate control of hazardous exposure; use elimination and source controls before relying on gloves or respirators.
Approve the actual product and method, not a generic chemical family. An SDS informs the assessment but is not the assessment. Substitute where feasible, enclose or capture releases, control contaminated rags and surfaces, select gloves for the actual substance and contact time, and provide hygiene and emergency arrangements.
A workplace exposure limit (WEL), where one exists, is substance-specific, airborne and time-averaged. Check current EH40 and the applicable GB or NI legal position before using a value. Being below a WEL does not prove skin exposure is controlled or health surveillance unnecessary. Decide monitoring and surveillance from the real risk, with competent interpretation.
For a product with a confirmed neurotoxic constituent, the assessor starts with the exact formulation and cleaning task. Remove the chemical step if the finish allows; otherwise validate a lower-risk product before specifying a closed dispenser and suitable local exhaust ventilation. A safety data sheet informs that decision but does not establish exposure or control effectiveness on its own.
Where the assessment calls for monitoring or health surveillance, competent specialists should interpret representative results and protect individual health information. A spill, failed capture or new symptom triggers prompt care and control review. The detailed five-level and ERICPD example names the owner, checks and stop condition for each measure; the HSE control principles put process and engineering measures ahead of PPE.
When should toxic neuropathy risk be escalated?
Stop uncontrolled exposure. Suspected acute poisoning needs immediate medical advice even without severe symptoms; stroke signs or severe illness need 999. Gradual new nerve symptoms need GP assessment while the workplace reviews controls.
A suspected harmful chemical contact needs prompt medical advice by the country-specific route above; do not use symptom severity as the gate. A serious release, collapse or stroke-like change needs 999 and safe isolation without unprotected rescue. A worker with new tingling or weakness should not keep doing an uncontrolled exposure task while waiting for proof of cause. Competent advice sets temporary task controls and any clinical review.
A toxic-neuropathy diagnosis is not automatically reportable under GB RIDDOR. NI RIDDOR 1997 Schedule 3 item 34 specifically lists peripheral neuropathy with work involving n-hexane or methyl n-butyl ketone; the employer checks written doctor diagnosis and current associated work activity; a self-employed person checks doctor notification and the same activity test. Check other incident criteria separately and record the decision. Reporting does not replace care, COSHH control or confidential health handling.
| Situation | Immediate action | Who should be involved |
|---|---|---|
| Sudden one-sided weakness, face or speech change | Call 999 immediately. | Emergency services; supervisor secures work area. |
| Possible harmful chemical contact, inhalation or swallowing, even without severe symptoms | Stop and isolate safely; seek immediate medical advice by the GB or NI poisoning route. Call 999 for severe illness or stroke signs; no unprotected rescue. | Emergency services/urgent clinician and first aider; share SDS without delaying care. |
| New tingling, numbness or grip/balance change | Pause uncontrolled exposure, advise GP assessment and review safety-critical task. | Worker, supervisor, OH and competent assessor. |
| Unknown substance or missing SDS | Hold use and identify product and actual process. | Purchaser/supplier and competent COSHH assessor. |
| LEV, glove or RPE unsuitable | Stop the affected exposure-producing step and arrange repair or replacement. | Supervisor, maintenance and occupational hygienist as needed. |
| Monitoring or surveillance concern | Seek competent interpretation; review exposure and other affected workers. | Hygienist/OH with privacy controls. |
| Possible reportable event | GB and NI rules differ. NI item 34 requires the specified neuropathy/activity pairing and doctor notification; symptoms alone are not a disease report. | Competent reporting lead, with documented rationale. |
Where does toxic neuropathy prevention fail?
Prevention fails when organisations underestimate skin exposure, rely on smell, ignore subtle symptoms or treat RPE as the main control.
Control failures can hide in open solvent rags, an extraction hood positioned for another task, softened gloves, product substitution, shared spaces and maintenance work. Dizziness during solvent use is an acute warning, not evidence of chronic neuropathy.
Compare the written COSHH assessment with work as done. Check exposure routes, product identity, duration, capture, cleaning and worker reports. Investigate promptly without making a clinical attribution from the symptoms alone.
| Failure or weak practice | How it develops | What good looks like |
|---|---|---|
| Smell used as warning | Workers stay until odour becomes strong. | Use exposure assessment, ventilation control and monitoring. |
| Skin exposure ignored | Soaked gloves, sleeves or rags create absorption risk. | Select chemical-resistant gloves and clean handling. |
| Generic COSHH sheet | Assessment does not match product, task or duration. | Task-specific COSHH with SDS and observation. |
| LEV not suited to task | Spray booth controls are assumed to protect bench cleaning. | Match capture method to source and breathing zone. |
| Symptoms dismissed | Early tingling or weakness is treated as personal. | Report, remove exposure and review controls. |
| RPE over-relied on | Respirator issued without source reduction or monitoring. | Substitution, enclosure, LEV and fit-tested RPE only where needed. |
| No learning from monitoring | Results are filed without control changes. | Competent interpretation and verified actions. |
What evidence shows toxic peripheral neuropathy risk is controlled?
Retain product identity, SDS, task exposure routes, control verification, monitoring and incident facts. Keep individual symptoms and diagnosis in a restricted clinical route while documenting necessary task adjustments.
| Evidence item | What it should show | Assurance question |
|---|---|---|
| COSHH assessment | Substance identity, routes, WELs, task duration and vulnerable groups are considered. | Does the assessment match work as done? |
| SDS and product review | Neurotoxic ingredients and control advice are understood. | Has substitution been considered? |
| Exposure monitoring | Air monitoring or biological monitoring is used where uncertainty or risk warrants it. | Are results interpreted by competent people? |
| LEV records | LEV is suitable, tested, maintained and checked before use. | Does capture protect the breathing zone? |
| Glove/PPE assessment | Material, breakthrough time, fit and contamination route are controlled. | Are gloves task-specific rather than generic? |
| Health surveillance | Programme exists where risk criteria require it. | Are findings acted on confidentially and promptly? |
| Training | Workers recognise symptoms, routes, hygiene and stop-work triggers. | Can workers explain why controls matter? |
| Action close-out | Defects, symptoms and monitoring findings lead to verified improvement. | Are repeated signals reduced? |
How should toxic peripheral neuropathy be assured?
Sample whether substitutes, enclosure, LEV, hygiene and RPE work during real tasks. Investigate trends in exposure or new symptoms without waiting for a confirmed occupational diagnosis.
| Assurance level | What to check | What good looks like |
|---|---|---|
| User checks | Workers check LEV, containers, gloves, RPE and hygiene before use. | Defects stop or pause work. |
| Supervisor checks | Task duration, exposure controls and waste practices are observed. | Work-as-done matches COSHH assessment. |
| Occupational hygiene | Monitoring confirms exposure assumptions. | Results drive control changes. |
| Occupational health | Health signals are interpreted confidentially and acted on. | Workers are protected from further harmful exposure. |
| Leadership review | Neurotoxic substances and surveillance trends are reviewed. | Resources are provided for substitution and engineering control. |
Which GB and NI legal duties and official guidance are relevant?
GB COSHH 2002 and NI COSHH 2003 are separate regimes; both require a risk-based substance-control approach. EH40 limits are approved for NI use, but no single WEL or health threshold applies to every substance or person.
Check the actual substance and process, the current amended regulation and the appropriate WEL where one exists. Health surveillance is risk-based under the relevant COSHH scheme; specific medical surveillance may apply to particular NI processes. Lead and asbestos have separate regimes. A symptom report alone does not establish a reportable disease. GB and NI RIDDOR lists differ: NI Schedule 3 item 34 specifically pairs peripheral neuropathy with work involving n-hexane or methyl n-butyl ketone; check medical notification and the specified activity before deciding.
| Duty or guidance | What it means | How to apply it |
|---|---|---|
| GB COSHH Regulations 2002 | Assess and prevent or adequately control hazardous substance exposure. | Use task-specific assessment, controls, monitoring and surveillance where required. Direct sources: GB COSHH Regulations 2002 |
| NI COSHH Regulations 2003 | Separate NI legal instrument for analogous exposure controls. | Use HSENI guidance and verify current amended text. Direct sources: NI COSHH Regulations 2003 |
| EH40 workplace exposure limits | Substance-specific airborne, time-averaged values; HSENI approves EH40 for NI COSHH. | Check current value and reference period; also control skin and other routes. Direct sources: HSE workplace exposure limits; HSENI EH40 approved for NI |
| Health surveillance | Required when relevant disease, detection and likelihood criteria are met. | Seek competent OH advice; distinguish from exposure or biological monitoring. Direct sources: HSE COSHH health surveillance; HSENI health and medical surveillance |
| Lead, asbestos and pesticide routes | Some substances/products have additional or separate rules. | Check specialist regime and current product authorisation, not a generic COSHH list. Direct sources: GB COSHH Regulations 2002; NI COSHH Regulations 2003 |
| GB RIDDOR 2013 and NI RIDDOR 1997 | GB 2013 and NI 1997 have distinct disease lists. NI Schedule 3 item 34 lists peripheral neuropathy with specified n-hexane or methyl n-butyl ketone work. | NI employer checks written doctor diagnosis and current associated work activity; a self-employed person checks doctor notification and that activity. Do not report symptoms alone as a diagnosed disease. Check GB criteria separately. Direct sources: HSE reportable occupational diseases; HSENI RIDDOR (NI) 97 booklet |
| ICO worker health information | Health details are special-category data. | Minimise, restrict and lawfully process individual records. Direct sources: ICO worker health information |
How can the hierarchy of controls reduce neurotoxic exposures that can damage peripheral nerves?
For this example, remove or redesign the exposure first; use lower-order controls only for the risk that remains. The example is a planning aid, not approval of a live task.
For Northern Ireland work, use this five-level framework to plan controls, then verify the applicable NI duties and HSENI guidance; HSE sources cited here state GB guidance.
Worked scenario: Repeated cleaning with an adhesive remover whose current safety data sheet confirms a neurotoxic solvent ingredient. The HSE five-level hierarchy order elimination, substitution, engineering, administrative controls and PPE. HSE COSHH assessment supplies the topic context. ERICPD maps elimination to elimination, Reduce to substitution and source reduction, Isolate to engineered separation, Control to engineering and administrative arrangements, and PPE to residual personal protection. Discipline is the continuing check, maintenance, supervision and learning that keeps every chosen level effective; it is not blame or a replacement for design controls. For each row, the owner must show why any stronger feasible measure was not chosen, check the residual risk and hold work when the stated control fails. Feasibility test: A surface finish may require chemical cleaning; the product owner must show why no-solvent and lower-risk methods failed before relying on capture and residual PPE.
ERICPD Discipline in this example: The COSHH owner reviews product changes, LEV checks and exposure evidence, observes work, and stops informal reintroduction of the old solvent. After a change, the supervisor verifies the strongest installed control at the workface and records any remaining exposure. If elimination or substitution was rejected, record the task-specific reason and revisit it when the process, equipment or site changes.
What can a voluntary management system add?
A management system can help assign owners, check live controls and correct failures, but it cannot certify that this particular task is lawful or safe. HSE explains the voluntary ISO 45001 context and the real task evidence remains decisive.
For this topic, check the substance and process, source controls, exposure evidence, symptom-reporting route and corrective action. The direct HSE topic guidance supplies the control context. Check the applicable GB or NI duty and the actual work before deciding that a control is effective. This is a SHARE management application, not an interpretation of an ISO clause.
What training and competence are needed?
Competence is a sound decision demonstrated in the real task, assessed by an appropriate person and revisited when conditions change.
Use a solvent task and new tingling/weakness scenario. Workers identify the SDS and stop/report route; supervisors control exposure without deciding the diagnosis; hygienists test the substance and control; clinicians assess causes and fitness. Reassess after a product substitution or abnormal exposure.
| Role | Learning to test | Demonstration | Assessor and evidence | Reassess when |
|---|---|---|---|---|
| Workers | Identify task chemicals, early symptoms and the stop/report route. | Demonstrate SDS access and safe handover. | Supervisor: observed task and concern response. | New substance or symptom concern. |
| Supervisors | Hold unsafe exposure and adjust work pending specialist review. | Run an early-symptom and control-failure scenario. | Manager: action log and restricted referral. | Control failure or changed method. |
| COSHH assessors and hygienists | Verify exact agents, WELs, combined routes and LEV/RPE effectiveness. | Defend sampling, maintenance and substitution decisions. | Technical lead: signed assessment and control evidence. | New product, result or process. |
| Occupational health and clinicians | Evaluate diagnosis, alternative causes and work function. | Give confidential, task-relevant advice. | Clinical lead: restricted case review. | Clinical or task change. |
| Senior managers | Resource prevention and verify the learning loop. | Challenge repeated symptoms or weak monitoring. | Safety lead: assurance sample and closed actions. | Trend or significant event. |
Which acronyms and terms are useful for toxic peripheral neuropathy?
These are the clinical and workplace terms used on this page.
| Acronym | Meaning | Plain-English use |
|---|---|---|
| A&E | Accident and Emergency | Emergency hospital department for urgent medical care. |
| COSHH | Control of Substances Hazardous to Health | GB COSHH 2002; NI has separate COSHH 2003 regulations. |
| GP | General Practitioner | Primary care doctor and common health signposting route. |
| HSE | Health and Safety Executive | Great Britain regulator and official guidance source. |
| NHS | National Health Service | UK public health service and official health guidance source. |
| OH | Occupational Health | Competent clinical advice route focused on work and health. |
| PPE | Personal Protective Equipment | Equipment worn where higher-order controls do not remove risk. |
| RIDDOR | Reporting of Injuries, Diseases and Dangerous Occurrences Regulations 2013 | GB 2013 reporting regulations; NI has a separate 1997 regime. |
| EH40 | Workplace Exposure Limits | HSE limits register approved for GB and NI COSHH use; verify current value. |
| LEV | Local Exhaust Ventilation | Engineering control used to capture airborne contaminants at source. |
| RPE | Respiratory Protective Equipment | Respiratory protection selected where other controls do not adequately control inhalation exposure. |
| SDS | Safety Data Sheet | Supplier hazard, control, first-aid and emergency information for substances. |
| WEL | Workplace Exposure Limit | Airborne exposure limit averaged over a specified reference period. |
| Distal neuropathy | Nerve damage often affecting feet or hands first. | Symptoms need clinical assessment; do not infer the cause at work. |
| Exposure route | The way a substance reaches the body, such as breathing it or skin contact. | Assess the actual product and task before choosing controls. |
Unlock another resource
You have used this month’s two free downloads. Publish a post in your own words to unlock one more resource, or choose SHARE Individual for 10 downloads per month.
You decide whether to share. If you do, use the relevant platform disclosure tools and do not make claims you do not genuinely hold.